the market is grappling with Virtus Health and the implications of its valuation for VEI; at 9 or 10 times ebitda, you get a comparable valuation of around 26m x 9 or 10 times - 42m net debt at 30 June, over 168m shares, being roughly $1.14 - $1.29. Different growth outlooks and specific business issues exist, yet fundamentally in same specialty medicals industry space etc
share price, page-5
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
